| Document |
Document Title |
|
WO/2008/062780A1 |
It is intended to provide 1- or 6-deoxy forms corresponding to all the aldohexoses, ketohexoses and sugar alcohols based on deoxyizumoring, and a method for systematically producing the same. A method for producing a deoxyketohexose and ...
|
|
WO/2008/059625A1 |
[PROBLEMS] To search for a glucokinase activator from rare sugars and provide a composition for treating a medical condition relating to the glucokinase activity which contains the above activator as the active ingredient. [MEANS FOR SOL...
|
|
WO/2008/056452A1 |
[PROBLEMS] To provide a drug or a food for specified health uses aiming at slowing the onset or progress of mobility impairment relating to amyotrophic lateral sclerosis. [MEANS FOR SOLVING PROBLEMS] An agent containing D-allose as the a...
|
|
WO/2008/056453A1 |
[PROBLEMS] To provide a composition for preventing periodontal disease (a preventive for periodontal disease) which has excellent anticarious properties, remains highly safe and stable over prolonged use and little affects flavors. [MEAN...
|
|
WO/2008/050740A1 |
It is intended to provide a method for decomposing cellulose and/or hemicellulose in a cellulose-based biomass to into monosaccharides or oligosaccharides with the use of high temperature/pressure water in the subcritical state and an ap...
|
|
WO/2008/047709A1 |
Disclosed is an NK1 receptor antagonist composition comprising a maltooligosaccharide having an antagonistic activity on an NK1 receptor as an active ingredient. Preferably, the maltooligosaccharide is contained in the NK1 receptor antag...
|
|
WO/2008/041843A1 |
The invention relates to nutritional and pharmaceutical compositions comprising non-digestible galactooligosaccharides (GOS) and uses thereof. In particular, it relates to the use of GOS species in preventing or treating disease caused b...
|
|
WO/2008/041131A2 |
The present invention is concerned with anticoagulants (i.e. substances that stop blood from clotting). More specifically, the present invention is concerned with orally available antithrombic oligosaccharides.
|
|
WO/2008/030033A1 |
Disclosed herein is a method of preparing a highly stable supersaturated solution of a hydrophilic substrate in an ionic liquid. When a supersaturated sugar solution is prepared through an indirect water-mediated method using an ionic li...
|
|
WO/2008/023796A1 |
Disclosed is a compound represented by the formula (I) below, which selectively accelerates biosynthesis of a proteoglycan, particularly a chondroitin sulfate proteoglycan or a heparan sulfate proteoglycan. Also disclosed is a pharmaceut...
|
|
WO/2008/021196A2 |
In general, the invention relates to marrow-derived adult progenitor cells (MAPCs) and their use in methods of treating various medical disorders, typically caused by or involving loss of cells or loss of cell function. These cells, when...
|
|
WO/2008/019468A1 |
A process for obtaining one or more than one salt of an organic acid(s), or organic acid(s), from an aqueous sugar stream comprising one or more than one mineral acid and the organic acid(s) is provided. The process comprises introducing...
|
|
WO/2008/018144A1 |
The invention is directed to a moisturizing agent characterized by comprising, as an active ingredient, a sugar containing 3-O-α-D-glucopyranosyl-D-glucose as a constituent unit. The moisturizing agent of the invention improves the wate...
|
|
WO/2008/010428A1 |
Disclosed is an immunomodulating agent which can be orally ingested continuously in a daily dietary life and is free of the concern about adverse side-effects. Also disclosed is an immunomodulating method. The immunomodulating agent comp...
|
|
WO/2008/004626A1 |
It is intended to provide a novel anhydrous crystalline maltose, a method of producing the same and a use thereof. This object can be achieved by providing anhydrous crystalline β-maltose having a melting point of from 154 to 159oC, a m...
|
|
WO/2008/001769A1 |
Disclosed is an intestinal immunity-activating substance or agent containing β-1,4-mannobiose.
|
|
WO/2008/000082A1 |
A synthetic procedure for the preparation of non-animal based lactose from 4'-epimeric analogue of lactose by use of orthogonal protecting groups, formation of a suitable leaving group at the 4'-position, stereochemical inversion by nucl...
|
|
WO/2008/001770A1 |
An anti-allergic composition or agent comprising β-1,4-mannobiose.
|
|
WO/2008/001696A1 |
The object is to hydrolyze a polysaccharide efficiently to produce other polysaccharide and/or a monosaccharide efficiently. The hydrolysis of a polysaccharide is an important means for the production of a monosaccharide which can be use...
|
|
WO/2007/129618A1 |
Ribose and 2-deoxyribose can inhibit a neutrophil activation/migration factor, and is therefore effective for the prevention or treatment of ischemia reperfusion injury. Ribose and 2-deoxyribose can also inhibit a neutrophil adherence fa...
|
|
WO/2007/128483A1 |
The invention relates to a crystalline isomaltulose product that, as a bulk material, has improved flow properties and does not tend to solidify over time, method for manufacturing this product and a new application of isomaltulose.
|
|
WO/2007/118949A1 |
The present invention relates to a method of preparing a non-hygroscopic pulverulent composition, comprising a step for the spray drying, without an atomization support, of an aqueous solution containing at least one initially hygroscopi...
|
|
WO/2007/111214A1 |
Disclosed is a novel trehalose compound having a high affinity to an adenosine A3 receptor. The trehalose compound is represented by the general formula (1): (1) wherein X and X’ independently represent a hydrogen atom or the like; Y a...
|
|
WO/2007/109561A1 |
Compounds comprising a saccharide molecule and a 5-deoxy-5-methylthio-xylofuranose (MTX) moiety or a 5-deoxy-5-methylsulfoxy-xylofuranose (MSX) moiety, and use of such compounds in methods for modulating inflammation and immune responses.
|
|
WO/2007/106034A1 |
Organic nitrites can be produced from a compound which is a mono/polyhydric alcohol or an aldehyde- or ketone-derivate thereof after de-aeration of the same, using NO gas, and stored in an environment saturated with gaseous NO. Organic n...
|
|
WO2007057920B1 |
A process is described for production of a chlorinated sucrose from a process stream containing a 6-O-protected chlorinated sucrose derived from chlorination of 6-O-protected sucrose wherein the process stream is treated under conditions...
|
|
WO2007054973B1 |
A process of production of trichlorogalactosucrose is described in which deacylation of sucrose-6-ester is achieved by subjecting the reaction mixture after chlorination, neutralization and adjustment of pH to 6.5 to 7 to deacylation by ...
|
|
WO/2007/088676A1 |
A process for producing a highly branched glucan; and a composition for use in such a process. There is provided a process comprising causing a branching enzyme, or homolog thereof, derived from Thermococcus kodakaraensis to act on amylo...
|
|
WO/2007/086100A1 |
It is intended to provide a composition having an effect of lowering blood pressure and/or inhibiting an increase in blood pressure characterized by containing an oligosaccharide mainly composed of mannose in which one or more and ten or...
|
|
WO/2007/072208A2 |
An oil product comprises a metal complex polymer solution for its esterification and fermentation reactions. The metal complex polymer is composed of oil, water, R-COOHs soluble saccharide (including sugar-metal) molecules, polymer with ...
|
|
WO/2007/063356A2 |
The present invention relates to monosaccharide derivatives as anti-inflammatory agents. The compounds of this invention can be useful for inhibition and prevention of inflammation and associated pathologies, including inflammatory and a...
|
|
WO/2007/061918A2 |
The invention pertains to an in situ process for producing fructooligosaccharides in a food product by contacting the food product with a fructosyltransferase to enzymatically convert sucrose to fructooligosaccharides in the food product...
|
|
WO/2007/049736A1 |
This invention provides a process for producing a natural product having stable quality with high recovery. There is also provided a method for concentration-crystallizing a natural product, characterized by comprising continuously measu...
|
|
WO/2007/048787A1 |
The invention relates to novel compounds of formula (I): H2N-CH(R1)-CH2-S-S- CH2-CH(R2)-CONH-R5, wherein R1 is a hydrocarbon chain, phenyl or benzyl radical, methylene radical substituted by a 5 or 6 atom heterocycle; R2 is a phenyl or b...
|
|
WO/2007/040163A1 |
This invention provides a novel optionally acylated cyclic tetrasaccharide-containing polyurethane derivative and a process for producing the same, and a novel cyclic tetrasaccharide modified polyurethane foam and a simple process for pr...
|
|
WO/2007/037249A1 |
Disclosed is a cellooligosaccharide composition comprising, as the main ingredient, at least one cellooligosaccharide selected from the group consisting of cellobiose, cellotriose, cellotetraose, cellopentaose and cellohexaose, which is ...
|
|
WO/2007/034748A1 |
Discloses is an immunomodulating agent in the gut, which can be ingested continuously in the daily dietary habit and does not produce any adverse side effect. The immunomodulating agent comprises a cyclic tetrasaccharide as an active ing...
|
|
WO/2007/026820A1 |
The object is to provide a novel application of D-allose (e.g., use for prevention of hypertension or hypercardia). Thus, disclosed is a composition for preventing the increase in blood pressure which comprises D-allose as an active ingr...
|
|
WO/2007/018124A1 |
It is intended to provide a means exerting a prolonged effect of enhancing the production of collagen. This object can be achieved by an agent for enhancing collagen production which contains, as the active ingredient, α,α-trehalose an...
|
|
WO/2007/011055A1 |
Disclosed is a process for producing a sugar chain derivative from a sugar chain mixture, which comprises a step (a) for obtaining a mixture of sugar chain derivatives by introducing a fat-soluble group into a sugar chain in the sugar ch...
|
|
WO/2007/010976A1 |
[PROBLEMS] To inhibit the excess increase in body weight induced by various causes and to reduce the overweight. [MEANS FOR SOLVING PROBLEMS] Disclosed are: a composition comprising D-psicose for use in the inhibition of the excess incre...
|
|
WO/2007/010973A1 |
[PROBLEMS] To control neuropathic pain produced by various mechanisms. [MEANS FOR SOLVING PROBLEMS] Disclosed is a composition for elimination, relief or reduction of neuropathic pain comprising, as an active ingredient, at least one sub...
|
|
WO/2007/010975A1 |
[PROBLEMS] To prevent the progression occurrence or ameliorate a condition of obesity, diabetes or metabolic syndrome. [MEANS FOR SOLVING PROBLEMS] Disclosed is a composition comprising D-psicose and/or a derivative thereof as an active ...
|
|
WO/2007/010974A1 |
[PROBLEMS] To provide a composition having an effect of preventing the rapid increase in blood glucose level upon the intake of a carbohydrate and/or a sugar. [MEANS FOR SOLVING PROBLEMS] Disclosed is a composition comprising D-allose wh...
|
|
WO/2007/001283A2 |
A process for the synthesis of beta linked low molecular weight polymers of galactosamine and glucosamine has been developed. Through the use of high amounts of activating agents, efficient coupling of stable monomers is achieved. Using ...
|
|
WO/2007/001282A2 |
Compositions containing enriched populations of beta linked low molecular weight polymers of galactosamine and glucosamine are provided. The compositions are useful, for example, as antibacterial additives for food and other edible appli...
|
|
WO/2006/132310A1 |
It is intended to provide a liquid for preventing tissue adhesion which is easy to use due to the stability of covering condition during an operation and generally applicable to a surgical operation and a method of preventing tissue adhe...
|
|
WO/2006/130994A1 |
The syntheses and in vitro antitumor properties of carbamate-containing, dicarbamate-containing, and ureido-containing phospholipid compounds that have an ether linkage at the C-1 position of a glycerol backbone, a carbamate, dicarbamate...
|
|
WO/2006/131599A2 |
The present invention relates to a method of profiling a cell population comprising a step of detecting the presence or absence of at least two biological markers in said cell population, wherein at least one of said markers is a cell su...
|
|
WO/2006/126633A1 |
A process for the production of an organic compound having one or more free hydroxyl and/or thiol groups by subjecting an organic compound whose hydroxyl and/or thiol groups are at least partially acylated (hereinafter referred to as “...
|
